Reeder, C. B., Reece, D. E., Kukreti, V., Chen, C., Trudel, S., Hentz, J., . . . Stewart, A. K. (2009). Cyclophosphamide, bortezomib and dexamethasone (CyBorD) induction for newly diagnosed multiple myeloma: High response rates in a phase II clinical trial.
Chicago-tyylinen lähdeviittausReeder, Craig B., et al. Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Induction for Newly Diagnosed Multiple Myeloma: High Response Rates in a Phase II Clinical Trial. 2009.
MLA-viiteReeder, Craig B., et al. Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Induction for Newly Diagnosed Multiple Myeloma: High Response Rates in a Phase II Clinical Trial. 2009.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.